Methotrexate Sodium
Brand name: Methotrexate
Rank #330 of 500 drugs by total cost
$32.4M
Total Cost
911,965
Total Claims
$32.4M
Total Cost
10,058
Prescribers
$36
Cost per Claim
226,818
Beneficiaries
1,753,268
30-Day Fills
$3,225
Avg Cost/Provider
91
Avg Claims/Provider
About Methotrexate Sodium
Methotrexate Sodium (sold as Methotrexate) was prescribed 911,965 times by 10,058 Medicare Part D providers in 2023, costing the program $32.4M. At $36 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 327 | Budesonide (Budesonide Dr) | $33.1M | 120,202 |
| 328 | Mavacamten (Camzyos) | $32.8M | 3,969 |
| 329 | Empagliflozin/Linagliptin (Glyxambi) | $32.6M | 34,331 |
| 330 | Methotrexate Sodium (Methotrexate) | $32.4M | 911,965 |
| 331 | Bumetanide (Bumetanide) | $32.4M | 735,077 |
| 332 | Voxelotor (Oxbryta) | $31.5M | 2,707 |
| 333 | Rivastigmine (Rivastigmine) | $31.4M | 118,567 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology